header

Medical affairs

Elekta Medical Affairs works closely with the medical community in order to better understand and to internally communicate the needs of the patient and of the practitioner. This insight drives research and development and helps to advance radiotherapy and stereotactic neurosurgery.

By becoming trusted scientific partners in international research collaborations, we are committed to secure, efficient data sharing through data registries. These collaborations lead to the discovery of clinical evidence that supports new, safe and effective uses of radiotherapy for the treatment of cancer and neurological disorders.

 

What's new

  • A great explanation of the online adaptive workflow by the extraordinary clinicians at UMC Utrecht

    Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases.
    Radiotherapy and Oncology 2019; 134: 50-54.
    Werensteijn-Honingh, A. M., et al.
    DOI: 10.1016/j.radonc.2019.01.024

  • Commentary on online adaptive radiation therapy and the opportunity to improve the treatment of lymphoma

    Reassessing the Role of Radiation Therapy for the Treatment of Lymphoma: Historical Perspective and Opportunities in the Era of Image-Guided and Adaptive Radiation Therapy.
    Journal of Oncology Practice. 2019; 15(4): 175-176.
    Schultz, C. J.
    DOI: 10.1200/JOP.19.00146

  • Testimonial from Medical College of Wisconsin on their MR-linac experience
    Read more
 

THIS CONTENT IS FOR SCIENTIFIC AND EDUCATIONAL PURPOSES - NOT FOR SALES OR PROMOTIONAL USAGE

 

Elekta Medical Affairs activities include

  • Organize and host customer research collaborations
  • Research and write clinical evidence reports
  • Attend major scientific meetings
  • Provide internal and external education

<span>Case Studies</span>


ACE Advanced Collapsed cone Engine

Bob van Veelen, Yunzhi Ma and Luc Beaulieu

Esteya® Electronic Brachytherapy – A Dedicated Solution for Improving Skin Cancer Patient Care

Rakesh Patel, MD, Director of Th e Targeted Radiation Institutes, Silicon Valley, CA, USA
Ate K. Loonstra, MSc, Manager Global Medical Aff airs, Elekta, Veenendaal, The Netherlands



Radiation Dose Reduction in OAR by using the Fletcher CT/MR Shielded Applicator and Oncentra® Brachy Advanced Collapsed cone Engine

Firas Mourtada, M.S.E., Ph.D., DABR, FAAPM
Helen F. Graham Cancer Center, Christiana Care Health System, Newark, DE
Associate Professor (Adj.) MD Anderson Cancer Center, Houston, TX
Associate Professor (Adj.) Thomas Jefferson University, Philadelphia, PA

SBRT for NSCLC using Versa HD™ with flattening filter-free beams (High Dose Rate mode) and Active Breathing Coordinator™

Department of Oncology, Department of Radiation Oncology, University Medical Center Mannheim

<span>Clinical presentations</span>

<span>Bibliographies</span>

<span>Ask medical affairs</span>